We are live on
!
Find out more
ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
824 hedge funds and large institutions have $31.3B invested in Alexion Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 204 funds opening new positions, 241 increasing their positions, 284 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
156% more funds holding in top 10
Funds holding in top 10: 18 → 46 (+28)
155% more first-time investments, than exits
New positions opened: 204 | Existing positions closed: 80
38% more capital invested
Capital invested by funds: $22.6B → $31.3B (+$8.67B)
28% more call options, than puts
Call options by funds: $559M | Put options by funds: $436M
17% more funds holding
Funds holding: 707 → 824 (+117)
15% less repeat investments, than reductions
Existing positions increased: 241 | Existing positions reduced: 284
Holders
824
Holders Change
+117
Holders Change %
+16.55%
% of All Funds
14.58%
Holding in Top 10
46
Holding in Top 10 Change
+28
Holding in Top 10 Change %
+155.56%
% of All Funds
0.81%
New
204
Increased
241
Reduced
284
Closed
80
Calls
$559M
Puts
$436M
Net Calls
+$123M
Net Calls Change
+$163M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$451M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$353M |
| 3 |
O
OrbiMed
New York
|
-$259M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$203M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$194M |